Carvolix SA (FRA:0JZ)

Germany · Delayed Price · Currency is EUR

5.34

+0.02 (0.38%)

Last updated: Oct 9, 2026, 3:25 PM CET

Market Cap	318.73M +478.6%
Revenue (ttm)	1.59M -69.8%
Net Income	-29.48M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39
Open	5.30
Previous Close	5.32
Day's Range	5.30 - 5.36
52-Week Range	1.28 - 7.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 25, 2026

About Carvolix

Carvolix SA, a medical technology company, develops and markets minimally invasive, minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company also offers TAVIPILOT Software, a robotic platform for transcatheter aortic valve implantat... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2011

Employees 59

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 0JZ

Financial Performance

In 2025, Carvolix's revenue was 900,000, a decrease of -83.18% compared to the previous year's 5.35 million. Losses were -24.97 million, 69.4% more than in 2024.

Financial Statements